Introduction {#s1}
============

The maintenance of osmotic balance is essential for the fitness and survival of bacteria. One mechanism used by prokaryotes to achieve this balance in hyperosmotic environments is the import of osmoprotectant molecules which balance internal and external osmolarity and prevent the flow of water out of the cell \[for review see [@B1]\]. Several membrane bound transporters exist with a variety of specificities for different molecules. One such transporter, ProP, senses hyperosmotic stress, and responds by importing proline and glycine betaine \[[@B2]-[@B4]\]. Examination of the transcriptional regulation of *proP* has revealed a complex network of both growth-phase and osmolarity dependent control. Briefly, *proP* transcription can occur from a proximal (P2) or distal (P1) promoter \[[@B5]\]. Transcription from the P2 promoter occurs as cells transition from the logarithmic-growth phase into stationary phase and is dependent upon the stationary-phase sigma factor RpoS. Transcription from the P2 promoter is further enhanced by the nucleoid-associated factor Fis \[[@B6],[@B7]\] and cyclic AMP receptor protein (CRP) \[[@B8]\]. The binding of Fis and CRP inhibit transcription from the P1 promoter \[[@B7],[@B9]\]. The P1 promoter is activated after subculture into fresh media, and is responsible for responding to upshifts in media osmolarity \[[@B5],[@B9],[@B10]\].

Beyond transcription, ProP activity is modulated by the cytoplasmic effector ProQ \[[@B11]\]. ProQ is a 232-residue protein, predicted to contain two structural domains, tethered by an unstructured linker \[[@B12],[@B13]\]. The N-terminal domain has been modeled on the structure of the RNA-binding, translational regulator FinO \[[@B12],[@B14]\], and the C-terminal domain has been modeled on the RNA chaperone Hfq \[[@B15]\]. Biochemical studies have been performed to support the structural predictions. The FinO-like domain, as well as the full length protein, are capable of binding to a model dsRNA template. The FinO-like domain also facilitates strand exchange, and both domains promote duplexing between complimentary strands of RNA \[[@B15]\]. Thus, ProQ behaves as an RNA chaperone. The mechanism behind ProQ regulation of ProP activity, however, remains largely unknown. Disruption of the *proQ* locus has no effect on the transcription of *proP*, but the proline uptake activity of ProP is significantly decreased in a Δ*proQ* strain \[[@B11],[@B16]\]. A post-translational mechanism was initially proposed after ProP protein levels appeared unchanged in a Δ*proQ* strain \[[@B16]\]; however, a direct physical interaction between ProP and ProQ has not been found. Most recently it was shown that, at osmolalities lower than those previously examined, ProP levels are decreased in a *proQ* mutant \[[@B15]\]. Additionally, as cells enter stationary phase, there is a modest decrease in the level of ProP in a *proQ* mutant compared to wild type \[[@B15]\]. In light of these findings, and the homology models comparing the ProQ domains to known RNA-binding proteins, a post-transcriptional mode of regulation is likely.

It had been reported in a high throughput study that ProQ was associated with ribosomes \[[@B17]\]. This led to the hypothesis that ProQ regulates ProP activity at the level of translation. In this study, we verify that ProQ is associated with ribosomes *in vivo*, and we characterize this association under various conditions. We also determine which domains of ProQ are important for association. We demonstrate that ProQ binds tightly, but non-selectively to *in vitro* transcribed *proP* mRNA, and we report the *K* ~*D*~ values for P1, P2, and an mRNA whose translation is not predicted to be dependent upon ProQ. Though we demonstrate that mRNA integrity is important for the association of ProQ with translating ribosomes, disruption of the *proP* locus, as well as the closely related *proU* operon, does not affect ProQ localization in polysome profiles. It had also been reported in a high throughput study that a *proQ* mutant exhibits decreased biofilm formation. Here we verify that result by complementing the phenotype and show that a *proP* mutant strain is not defective in biofilm formation. It follows that ProQ may act as a translation factor for a broader subset of mRNAs.

Materials and Methods {#s2}
=====================

Bacterial strains and growth conditions {#s2.1}
---------------------------------------

*E. coli* strains used in this study are listed in [Table 1](#pone-0079656-t001){ref-type="table"}. Strains were grown at 37°C in Luria-Bertani (LB) broth (10 g tryptone, 5 g yeast extract, 10 g NaCl per liter). Cultures of JM6733 containing plasmids were supplemented with 20 µg/mL chloramphenicol (BioExpress). JM6733 (Δ*proQ::KAN*), JM6753 (Δ*proP::KAN*), JM6754 (Δ*proV::KAN*), JM6755 (Δ*proW::KAN*), and JM6877 (Δ*proX::KAN*) were constructed by P1 transduction \[[@B18]\] of KEIO-collection mutants, JW5300, JW4072, JW2652, JW2653, and JW2654 respectively, into a clean BW25113 background \[[@B19]\]. JM6881 (Δ*proVWX::KAN*) was made using the λ~red~ recombination system \[[@B20]\]. JM6906 (Δ*proP::FRT*) was constructed by transformation of JM6753 (Δ*proP::KAN*) with pCP20, and subsequently, screening for sensitivity to kanamycin \[[@B21]\]. JM6926 (Δ*proP::FRT*, Δ*proVWX::KAN*) was constructed by P1 transduction of JM6906 by phage grown on JM6881. Genotypes were verified using primers flanking the genomic regions of interest ([Table 2](#pone-0079656-t002){ref-type="table"}). Culture growth was monitored by measuring the absorbance at 600 nm.

10.1371/journal.pone.0079656.t001

###### Strains and Plasmids.

  Strain       Genotype                                                                                         Origin
  ------------ ------------------------------------------------------------------------------------------------ --------------------
  BW25113      ∆(*araD-araB*)*567*, ∆*lacZ4787*(::rrnB-3), lambda^-^, *rph-1*, ∆(*rhaD-rhaB*)*568*, *hsdR514*   \[[@B20]\]
  JM6733       BW25113, Δ*proQ*::KAN                                                                            \[19\], This study
  JM6753       BW25113, Δ*proP*::KAN                                                                            \[19\], This study
  JM6754       BW25113, Δ*proV*::KAN                                                                            \[19\], This study
  JM6755       BW25113, Δ*proW*::KAN                                                                            \[19\], This study
  JM6877       BW25113, Δ*pro*X:KAN                                                                             \[19\], This study
  JM6881       BW25113, Δ*proVWX*::KAN                                                                          This study
  JM6906       BW25113, Δ*proP*::FRT                                                                            This study
  JM6926       BW25113, Δ*proP*::FRT, Δ*proVWX*::KAN                                                            This study
  Plasmid      Description                                                                                      Origin
               pCA24N-ProQ                                                                                      \[[@B23]\]
  pDS1         pCA24N-*ProQΔ115N*                                                                               This study
  pDS2         pCA24N-*ProQΔ181C*                                                                               This study
  pDS3         pCA24N-*ProQΔ124-180*                                                                            This study
  pDS4         pCA24N-*ProQ116-180*                                                                             This study
  pDS5         pCA24N-*ProQ2-123*                                                                               This study
  pDS6         pMCSG7-ProQ                                                                                      \[24\], This study
  pMR20        pMR20 empty vector                                                                               \[[@B27]\]
  pMR20-ProQ   pMR20 containing *proQ* ORF plus 500 bp upstream                                                 This study
  pCP20        Flip Recombinase containing vector                                                               \[[@B21]\]

10.1371/journal.pone.0079656.t002

###### Oligonucleotide sequences.

  Name                 Sequence (5' - 3')                                                                               Function
  -------------------- ------------------------------------------------------------------------------------------------ ---------------------------------------------------
  DS001                GAT CGA GCT CTC TGA CAT TTC AGC TCT GAC T                                                        Construction of *proQΔ124-180*
  DS002                GAT CGA GCT CTT CGC GTT TTT TCG CTT GCT G                                                        Construction of *proQΔ124-180* and *proQ1-123*
  DS003                GAT CGA GCT CCC CCT ATG CGG CCG CTA A                                                            Construction of *proQΔ181C* and *proQ1-123*
  DS004                GAT CGA GCT CAA CCG GGG TGT GCT GTT C                                                            Construction of *proQΔ181C*
  DS005                GAT CGA GCT CGA ACA GCA AGC GAA AAA ACG C                                                        Construction of *proQΔ115N* and *proQ181-232*
  DS006                GAT CGA GCT CCC TCA GGG CCG GAT CCG T                                                            Construction of *proQΔ115N* and *proQ181-232*
  DS007                GAT CGG TAC CCC CCT ATG CGG CCG CTA A                                                            Construction of *proQ116-180*
  DS008                GAT CGG TAC CAA CCG GGG TGT GCT GTT C                                                            Construction of *proQ116-180*
  DS037                GAT CGA GCT CGT CAT TAA CTG CCC AAT TCA GGC GTC                                                  pBluescript-*proPp1*
  DS038                GAT CGA GCT CAG AGA TTG CAT CCT GCA ATT CCC G                                                    pBluescript-*proPp2*
  DS039                GAT CGG TAC CTT ATT CAT CAA TTC GCG GAT GTT GCT GC                                               pBluescript-*proP* reverse
  rpoS-T7-forw-SacII   CCG CGG CCG ACA ATT ACG TAT TCT GA                                                               pBluescript-*rpoS*
  rpoS-T7-rev-PstI     CTG CAG TTG AGA CTG GCC TTT CTG AC                                                               pBluescript-*rpoS*
  DS046                TAC TTC CAA TCC AAT GCC ATG GAA AAT CAA CCT AAG TTG                                              Construction of 6His-TEV-ProQ
  DS047                TTA TCC ACT TCC AAT GTT ATC AGA ACA CCA GGT GTT CTGC                                             Construction of 6His-TEV-ProQ
  DS048                CGC AGG ATA ATC AAC GGA TAA CG                                                                   *proQ* genotyping
  DS049                ATT TGA TCA GCA CGC GTG ATA TC                                                                   *proQ* genotyping
  DS054                CAG AGA TTG CAT CCT GCA ATT CCC                                                                  *proP* genotyping
  DS055                CCT GAT AAG ACA GCG TCA CAT CAG                                                                  *proP* genotyping
  DS056                GCT CGC ATC AAT ATT CAT GCC ACA                                                                  *proV* genotyping
  DS057                GTA CTG GTC AGC CAG TCA GCA                                                                      *proV* genotyping
  DS058                TAG CGA GTT GCT CTC TCA TGT CG                                                                   *proW* genotyping
  DS059                AGT TTG TGT AGA GAT AAG CGT GGC                                                                  *proW* genotyping
  DS060                GGC CCT GTT GGT CTG CTG AC                                                                       *proX* genotyping
  DS061                GTC GCA TCA GGC ATT GTG CAC                                                                      *proX* genotyping
  DS062                GGT TTC TGG CTG CCG ATG TAT                                                                      *proVWX* (*proU*) genotyping
  DS063                CAG CCT ACA CCC TGC TGC GGG TAG TGA TAT                                                          *proVWX* (*proU*) genotyping
  DS076                GAT CTC ACT AGC CAT CCT GCA AAC CTT CAC G                                                        *proP in vitro* transcription template
  DS077                ATT GGG TAA TAT ATC GAC ATA GAC AAA TAA AGG AAT CTT TCT ATT GCA TGG TGT AGG CTG GAG CTG CTT CG   *proVWX* (*proU*) deletion
  DS078                CAA AAA CGC CTT ATC CGC CCG AAT AAA AAT TAC TTC TGC GCT GCC AGC GCC ATA TGA ATA TCC TCC TTA G    *proVWX* (*proU*) deletion
  DS083                GAT CGA GCT CGT GCG TTG TTA TAT GAG CGT C                                                        Construction of pMR20-ProQ
  DS084                GAT CGG TAC CTC AGA ACA CCA GGT GTT CTG C                                                        Construction of pMR20-ProQ
  pBSIVTforward        CGT TGT AAA ACG ACG GCC AGT G                                                                    *proP* and *rpoS in vitro* transcription template
  rpoSIVTreverse       GAT CTC ATT AGG TTG CGT ATG TTG AG                                                               *rpoS in vitro* transcription template

Preparation of cell lysates for ribosomal fractionation {#s2.2}
-------------------------------------------------------

Isolation of ribosomal species was performed as previously described \[[@B22]\] with the following exceptions. Cultures of LB broth were inoculated with 1/200^th^ volume of a stationary overnight culture. For strain JM6733 (Δ*proQ::KAN*) containing the indicated plasmids, Isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to a final concentration of 15 µM after the first 30 min of incubation to induce the expression from the *lac* promoter. Cell pellets were resuspended in 700 µL of lysis buffer containing 10 mM Tris pH 7.5, 10 mM MgCl~2~, and 60 mM NH~4~Cl per 100 mL of starting culture, flash frozen in liquid nitrogen, and stored at -80°C. 300 µm glass beads were added to frozen cells as they thawed. Cells were lysed by repeated vortexing for 1 min followed by 1 min on ice for a total time of 10 min. The lysate was cleared by centrifugation at 21,000 x g for 10 min at 4°C. For subunit dissociation experiments, cells were lysed without addition of chloramphenicol, in buffer containing 10 mM Tris pH 7.5, 1 mM MgCl~2~, and 60 mM NH~4~Cl and clarified as described. The absorbances of clarified lysates were measured at 260 nm.

MNase digestion of ribosomes {#s2.3}
----------------------------

Lysates were prepared as previously described. 13 OD~260~ units of lysate were transferred to a clean, 1.5 mL microcentrifuge tube. CaCl~2~ was added to a final concentration of 5 mM. BSA (NEB) was added to a final concentration of 0.1 mg/mL. 4 µL of MNase (NEB) were added and the final reaction volume was brought up to 400 µL with lysis buffer. Digests were carried out at room temperature for 30 min. Mock digests were set up as controls, containing all reagents except MNase.

*In vitro* binding of ProQ and 70S ribosomes {#s2.4}
--------------------------------------------

70S ribosomes (NEB) were incubated with an equimolar ratio of purified ProQ in polysome lysis buffer, with or without equimolar P2 mRNA. Reactions were loaded onto sucrose gradients and separated as described.

Ribosomal fractionation {#s2.5}
-----------------------

Ribosomal species were separated on sucrose gradients ranging from 10% to 47% sucrose in pollyalomar ultracentrifuge tubes (Beckman). Sucrose was dissolved in the following buffer: 100 mM NH4Cl, 10 mM Tris pH 7.5, 10 mM MgCl~2~. 550 µL of 47% sucrose was added into the bottom of the tube and placed at -80°C until frozen. Next, 42% sucrose was added and the tube was placed back at -80°C until frozen. This method was repeated until the gradient was complete, using the following concentrations of sucrose: 47%, 42%, 37%, 32%, 27%, 22%, 17%, 12%, 10%. Gradients were stored at -80°C. Gradients were allowed to thaw completely at room temperature. 13 OD~260~ units of lysate were applied to the top of each gradient. Gradients were balanced and submitted to ultracentrifugation in an SW50.1 (Beckman) rotor at 41K RPM for 1.5 h at 4°C. After ultracentrifugation, fractionation was performed as previously described \[[@B22]\]. Separation of dissociated subunits was done by ultracentrifugation on 20% sucrose cushions in an SW40TI (Beckman) rotor at 23 K RPM for 15 h at 4°C. Fractionation was performed as previously described.

Mutant His-ProQ constructs {#s2.6}
--------------------------

Mutant constructs were made using pCA24N-ProQ from the ASKA collection \[[@B23]\] as a template for inside-out PCR. A *Sac*I restriction endonuclease site was added to both primers ([Table 2](#pone-0079656-t002){ref-type="table"}), allowing linear products from PCR amplification to be digested and self-ligated in frame to create pDS1-pDS5 ([Table 1](#pone-0079656-t001){ref-type="table"}).

ProQ purification and Antibody production {#s2.7}
-----------------------------------------

A culture of JM6733 (Δ*proQ::KAN*), transformed with pCA24N-ProQ, was grown to late-logarithmic growth phase (OD~600~ ^≈^ 0.8) at 37°C in LB media. Production of a 6 histidine epitope-tagged ProQ was induced by addition of IPTG to a final concentration of 1mM, and the culture was shifted to ambient temperature with shaking. Cells were harvested 18 h post induction. Cells were resuspended in 8 mL of lysis buffer (10% glycerol, 20 mM Tris pH 8.0, 500 mM NaCl, 10 mM Imidazole, and 1 mM β-Mercaptoethanol) and complete EDTA-free protease inhibitors (Roche) per 1 g of wet pellet weight and disrupted by 5 passes through a french press. Insoluble debris was cleared via centrifugation at 15,000 RPM for 30 min at 4°C in an SA-600 rotor (Sorvall). Nickel affinity chromatography was performed using Ni-NTA Superflow resin (Qiagen) as per manufacturer's directions with the following exceptions. After batch binding of 6His-ProQ the column was washed with 5 column volumes (CVs) of lysis buffer. Additional 5 CV washes were done with lysis buffer containing 1 M NaCl, as well as lysis buffer containing 20 mM and 30 mM Imidazole. 6His-ProQ was eluted from the column using 5 CVs of lysis buffer containing 500 mM Imidazole. Protein purity was monitored via SDS-PAGE, and the eluent was dialyzed overnight at 4°C in a low-salt buffer (10% glycerol, 20 mM Tris pH 8.0, 100 mM NaCl, 1 mM β-Mercaptoethanol). Cation exchange chromatography was performed using SP Sepharose Fast Flow resin (GE Healthcare). Cation exchange resin was equilibrated with 5 CVs of low salt buffer. Dialyzed 6His-ProQ was incubated with equilibrated resin for 30 min at room temperature with occasional agitation. After batch binding, the column was washed with 5 CVs of low salt buffer. 6His-ProQ was eluted from the column using a gradient of NaCl (100 mM to 1 M). 6His-ProQ purity was monitored via SDS-PAGE, and purified 6His-ProQ was again dialyzed against a low-salt buffer. After dialysis, 6His-ProQ was concentrated using a centrifugal filter with a 3 kDa molecular weight cutoff (Amicon), as per manufacturer's directions. Purified 6His-ProQ was quantified using an ND-1000 spectrophotometer (NanoDrop Technologies, Inc.) and 600 µg was sent for antibody production in a rabbit host (Cocalico Biologicals, Inc).

Western-blot analysis of ribosomal fractionations {#s2.8}
-------------------------------------------------

Denaturing SDS-PAGE loading buffer (50 mM Tris pH 6.8, 2% Sodium dodecyl sulfate (SDS), 10% glycerol, 1% β-Mercaptoethanol, 13 mM EDTA, 0.02% Bromophenol blue) was added to trichloroacetic acid (TCA) precipitated ribosomal fractions. Briefly, TCA was added to polysome gradient fractions to a final concentration of 15% and incubated at 4°C for 30 min. The precipitant was pelleted in a microcentrifuge at maximum speed for 10 min. The supernatant was removed and the pellet was washed twice with ice cold 100% acetone. Proteins were separated via SDS-PAGE and transferred to nitrocellulose (GE Water & Process Technologies). Protein detection was carried out using antibodies against ProQ (1:5000 in 5% dry milk in PBS + 0.1% Tween20) and ribosomal proteins L3 (1:5000 in same) and S2 (1:5000 in same). Antibodies to L3 and S2 were a generous gift from Catherine Squires.

Copy number calculation {#s2.9}
-----------------------

*proQ* was cloned into vector pMCSG7 as described \[[@B24]\] using DS046 and DS047 ([Table 2](#pone-0079656-t002){ref-type="table"}) to make pDS6 ([Table 1](#pone-0079656-t001){ref-type="table"}), which adds an N-terminal 6-Histidine epitope tag, followed by a TEV cleavage site. ProQ was purified as previously described with the following exceptions. After the first nickel affinity column, elution fractions were pooled and dialyzed overnight in the presence of 6His-TEV protease. A second nickel affinity column was used to remove TEV protease and the flow through was collected. Fractions were analyzed via SDS-PAGE and pooled for cation-exchange chromatography. Purified ProQ was quantified using a Bradford assay (Biorad). Known amounts of ProQ, as well as whole cell lysate from a known number of wild type BW25113 *E. coli* cells were loaded onto SDS-PAGE and transferred to nitrocellulose for western-blot analysis using anti-ProQ antibodies. Band intensities were quantified using ImageJ and cellular concentration was calculated.

In vitro transcription {#s2.10}
----------------------

The *proP* genomic region was cloned into pBluescriptKS+ in two forms, starting at either -182 (*proP* P1, DS037, DS039) or -95 (*proP* P2, DS038, DS039). The *rpoS* genomic region was cloned into pBluescriptKS+ (rpoS-T7-forw_SacII, rpoS-T7-rev-PstI). PCR was performed to amplify the plasmid DNA for use as an *in vitro* transcription template. The forward primer maintained the integrity of the T7 polymerase dependent promoter (pBSIVTforward), and the reverse primer added a stop codon after glycine 245 for *proP* P1and P2 (DS076) and after tyrosine 147 for *rpoS* (rposIVTreverse), yielding mRNAs with sizes of 927 bp, 840 bp, and 1041 bp respectively. *In vitro* transcription was carried out as described previously \[[@B25]\], and the mRNAs were checked for quality using urea-acrylamide gel electrophoresis and TAE-agarose electrophoresis. The mRNA concentrations were determined by electrophoresis on a TAE-agarose gel and quantitative comparison to the RiboRuler High Range RNA Ladder (Thermo Scientific).

Tryptophan fluorescence {#s2.11}
-----------------------

Purified ProQ was dialyzed into 10% glycerol, 20 mM HEPES pH 7.5, and 100 mM NaCl. The concentration was determined using Bradford assay. For binding experiments, ProQ was diluted to a final concentration of 20 nM in the same buffer plus 0.005% BRIJ35. Temperature was held constant at 20°C and tryptophan was excited at 295 nm and fluorescence was monitored at 355 nm using a QuantaMaster4 (Photon Technology International). The excitation wavelength was chosen to avoid any possible inner-filter effect stemming from the use of nucleic acids as ligands \[[@B26]\]. Increasing amounts of *in vitro* transcribed mRNAs were added to the reaction and the change in fluorescence was observed.

Biofilm assays {#s2.12}
--------------

Plasmid pMR20-ProQ was constructed by cloning the amplicon from primers DS083 and DS084 into pMR20 \[[@B27]\] cut with *Kpn*I and *Sac*I ([Table 2](#pone-0079656-t002){ref-type="table"}). Biofilm assays were performed with modifications of previous protocols \[[@B28],[@B29]\] as follows. Strains were grown overnight in LB + 12.5 µg/mL tetracycline. 30 µL of the saturated overnight was inoculated into 1 mL of LB without salt (10 g tryptone, 5 g yeast extract) plus 12.5 µg/mL tetracycline, in a previously unused borosilicate test tube. Tubes were incubated at 25°C without shaking for 6 d. After 6 d, the media and loose cells were removed and the OD~600~ was measured. Tubes were gently rinsed by submerging in deionized water 5 times and allowed to air dry. Biofilms were stained using 1% crystal violet for 20 min. Tubes were again rinsed by submerging in deionized water to reduce background staining. Biofilms were resuspended completely in 0.5% SDS and the OD~600~ was measured. Relative biofilm formation was calculated as described previously \[[@B28]\].

Results {#s3}
=======

ProQ associates with translating ribosomes {#s3.1}
------------------------------------------

In order to verify the localization of ProQ on ribosomes, the soluble lysates from wild type *E. coli* (strain BW25113) were separated on sucrose density gradients ([Figure 1A](#pone-0079656-g001){ref-type="fig"}). Western-blot analysis of the resulting fractions revealed that ProQ predominantly associates with 70S and translating ribosomes, and to a lesser extent, at the top of the gradient and in fractions corresponding to the 30S ribosomal subunit. Antibodies against small and large ribosomal subunit proteins validated the assignment of the peaks in the UV-absorbance trace. Deletion of some ribosome-associated factors can lead to ribosomal defects and perturbation of the polysome profile \[[@B22]\]. Profiles from a Δ*proQ* strain were indistinguishable from wild type (data not shown), and therefore, ProQ is not likely a ribosome assembly factor, nor is it required for the translation of the majority of mRNAs in the cell.

![Ribosome association of ProQ under native and dissociating conditions.\
Polysome profiles (254 nm) from wild type cell extracts in (A) associating conditions (10 mM Mg^2+^) and (B) dissociating conditions (1 mM Mg^2+^) are shown. Western-blot analysis of TCA-precipitated fractions using antibodies to ProQ, small ribosomal subunit protein 2 (S2), and large ribosomal subunit protein 3 (L3) are shown and aligned to the UV-absorbance trace. Whole cell extracts from wild type (BW25113) and Δ*proQ* (JM6733) are included, as is the soluble lysate (Load). UV-absorbance peaks correspond to (L to R): Free RNA/protein, 30S, 50S, 70S, and polysomes.](pone.0079656.g001){#pone-0079656-g001}

Since the 30S and 50S ribosomal subunits work in tandem, but with separate roles during translation, identifying the subunit with which ProQ associates provides a clue as to the function of ProQ during translation. When isolated at lower concentrations of Mg^2+^, 70S ribosomes dissociate into 30S and 50S subunits \[[@B30]\]. At 1 mM Mg^2+^, the 70S and polysome species were predominantly dissociated, as revealed by the UV-absorbance trace and localization of S2 and L3 ([Figure 1B](#pone-0079656-g001){ref-type="fig"}). A large proportion of ProQ was found at the top of the gradient, but ProQ that did migrate into the gradient peaked with the 30S subunit but not with the 50S subunit. These data are consistent with the localization under non-dissociating conditions ([Figure 1A](#pone-0079656-g001){ref-type="fig"}). Thus, ProQ appears to preferentially associate with the 30S subunit.

The N-terminus and linker regions are necessary for ribosome association {#s3.2}
------------------------------------------------------------------------

ProQ is predicted to contain two structural domains, tethered by a positively charged linker region. The N- and C-termini have been modeled on the RNA binding proteins FinO and Hfq respectively \[[@B12],[@B15]\]. Using available bioinformatic tools to predict secondary structure, disordered regions, and nucleic acid binding propensity \[[@B31]--[@B33]\], we assigned the boundaries of the linker region as amino acids E116-V180. Assignment of the lower bound was the most difficult. The nucleic acid binding predictor, BindN, indicated the presence of an unstructured positively charged domain starting at E116. The secondary structure predictor, PSIPRED, indicated the presence of an alpha helix until A124. Domain constructs were made using the 6HIS-ProQ plasmid from the ASKA collection \[[@B23]\] as a template. A schematic of each construct is provided ([Figure 2A](#pone-0079656-g002){ref-type="fig"}). To determine the regions of ProQ that are necessary for its association with the ribosome, each ProQ construct was expressed in a Δ*proQ* background, such that it was the only copy of ProQ in the cell. We could not detect a ProQ variant expressing only the C-terminal domain (*proQ181-232*). The distribution of ectopically expressed 6HIS-ProQ ([Figure 2B](#pone-0079656-g002){ref-type="fig"}) was similar to that of ProQ from wild type cells ([Figure 1A](#pone-0079656-g001){ref-type="fig"}); although, in addition to an association with 70S, polysome, and 30S fractions, there was a general increase in ProQ throughout the gradient. This broader distribution may reflect a higher than normal cellular concentration caused by exogenous expression or a decrease in affinity for translating ribosomes due to the N-terminal 6HIS-epitope tag. The high rate of speed and high G-forces produced during polysome fractionation can physically disrupt binding interactions, so addition of the epitope tag may cause dissociation of 6HIS-ProQ from ribosomes as it progresses through the gradient. Deletion of the C-terminal Hfq domain (*proQΔ181C*) did not affect association with the ribosomes ([Figure 2B](#pone-0079656-g002){ref-type="fig"}), and therefore, this part of the protein is not required for ribosome localization. In contrast, both the N-terminus and linker regions are required for ribosome association, as the majority of *proQΔ115N* and *proQΔ124-180* were found at the top of the gradient. Consistently, removal of the C-terminus and linker domains together (*proQ2-123*) caused ProQ to be found at the top of the gradient. Moreover, the linker domain (*proQ116-180*) was not sufficient for ribosome association. These data suggest that both the N-terminal FinO domain and the linker regions are required for ribosome association of ProQ.

![Ribosome association of plasmid encoded *proQ* mutant constructs in polysome profiles.\
(A) Schematic representation of *proQ* mutant constructs expressed from the IPTG inducible plasmid pCA24N. The predicted RNA binding region is colored in black, and amino-acid boundaries of each construct are labeled. (B) Mutant constructs were expressed as the lone copy of *proQ*. Western-blot analysis of TCA-precipitated fractions from the separation of ribosomal moieties on sucrose density gradients was performed. Whole cell extracts of cells after induction were included (Induced) along with soluble lysate (Load). Position of the 30S, 50S, 70S, and Polysome species are indicated based on western-blot localization of S2 (data not shown).](pone.0079656.g002){#pone-0079656-g002}

ProQ interacts with the mRNA being translated {#s3.3}
---------------------------------------------

The comigration of ProQ into sucrose gradients with translating ribosomes could occur because of a physical interaction with the ribosome directly or because of an interaction with the mRNA bound by a 30S particle and/or 70S particle. To determine the nature of the ProQ association with ribosomes, we partially hydrolyzed the mRNA in cell lysates with micrococcal nuclease (MNase) under conditions that did not perturb the integrity of the highly structured, and relatively RNase insensitive, ribosome. As expected, the small ribosomal protein S2 was found associated with the remaining 70S and 2-mers, and no appreciable amount of S2 was found at the top of the gradient. This supports the claim that the integrity of these ribosomes was maintained. In mock treatments, mRNAs with up to 4 ribosomes are seen in sucrose gradients, and ProQ associates with all translating ribosomes (both the 70S and polysome forms) ([Figure 3A](#pone-0079656-g003){ref-type="fig"}). After treatment with MNase, the level of total polysomes was decreased concomitant with a large increase in free 70S ribosomes ([Figure 3A](#pone-0079656-g003){ref-type="fig"}) and consistent with cleavage of intra-ribosome mRNA. Strikingly, in contrast to a robust association of ProQ with 2-mer and 3-mer polysomes in untreated samples, ProQ was almost absent from these particles in the MNase treated samples. Additionally, a significant amount of ProQ was found at the top of the gradient, consistent with dissociation of ProQ from the ribosomes after disruption of mRNA. Thus, ribosome association of ProQ appears to be partially dependent on the mRNA being translated. In order to support this finding, we also performed *in vitro* binding experiments with mRNA-free 70S ribosomes. 70S ribosomes were incubated with equimolar purified ProQ, with or without *proP* P2 mRNA. After incubation, the reactions were applied to sucrose gradients and separated as before ([Figure 3B](#pone-0079656-g003){ref-type="fig"}). Though some ProQ is found in the gradient under the 70S peak, indicating a weak interaction with 70S ribosomes, the bulk of the ProQ is located in the fractions not corresponding to the 70S ribosomes. It is also worth noting that when *proP* mRNA was added, we consistently observed the concentration of ProQ in the gradient peaking around fraction 5. The most likely explanation for this result is that ProQ is binding to the *proP* mRNA and migrating to this region of the gradient.

![Ribosome association of ProQ after mRNA disruption.\
(A) Cell lysates were left untreated (solid line) or treated with limited MNase (dashed line) and ribosomal species separated on sucrose gradients. The positions of ProQ and ribosomal protein S2 in the resulting TCA-precipitated fractions is determined by western-blot analysis. (B) mRNA free 70S ribosomes were mixed with equimolar amounts of purified ProQ without (foreground) or with (background) the addition of equimolar P2 mRNA before application to sucrose gradients. The position of ProQ and ribosomal protein S2 in the resulting TCA-precipitated fraction is determined by western-blot analysis.](pone.0079656.g003){#pone-0079656-g003}

ProQ does not bind selectively to *proP* mRNA {#s3.4}
---------------------------------------------

It has been demonstrated that ProQ can bind to a model RNA substrate *in vitro* \[[@B15]\]. However, the model double-stranded substrate used previously was relatively small (39 bp in duplex form) compared to the size of an mRNA. To further understand the RNA binding properties of ProQ, binding experiments were performed using purified ProQ and *in vitro* transcribed mRNA substrates ([Figure 4A](#pone-0079656-g004){ref-type="fig"}). One possibility is that ProQ acts as a *proP* mRNA-specific translation factor. If true, we would predict that ProQ should interact preferentially with *proP* mRNA *in vitro*. We tested the ability of ProQ to bind to mRNA made from the *proP* P1 and P2 promoters, as well as an unrelated mRNA, *rpoS* (see methods). Under the conditions tested, ProQ showed no preference for *proP* mRNA transcribed from promoter P1 or P2, and the binding affinity for *proP* P1 and P2 were similar (17.0 ± 6.1 nM and 11.6 ± 2.7 nM, respectively; [Figure 4](#pone-0079656-g004){ref-type="fig"}). Interestingly, ProQ also bound tightly to *rpoS* mRNA (19.5 ± 7.8 nM; [Figure 4](#pone-0079656-g004){ref-type="fig"}). These slight differences among the *K* ~*D*~ values are not sufficient to confer selectivity *in vivo*. Comparisons of our values to those previously reported for the model substrate are in agreement \[[@B15]\], though we report consistently lower *K* ~*D*~ values. ProQ binds non-selectively to all mRNAs tested, but it does not bind to DNA, and we include the results as a negative control. To compliment the determination of the *K* ~*D*~ values for specific mRNAs we sought to determine the cellular abundance of ProQ. Using quantitative western-blot analysis, we estimate the cellular copy number of ProQ to be 1.90 x 10^3^ ± 324 (95% confidence interval, data not shown). Assuming a cellular volume of 1.3 µm^3^ \[[@B34]\], the cellular concentration of ProQ is 2.43 ± 0.414 µM. This number is comparable to another estimate for the ProQ copy number obtained by high-throughput proteomic analysis of *E. coli* cytosolic proteins \[[@B35]\], and at approximately 2,000 copies/cell, ProQ is in the top 25% in terms of protein abundance.

![mRNA binding kinetics monitored by native tryptophan fluorescence.\
(A) 20 nM ProQ was titrated with increasing amounts of *in* *vitro* transcribed mRNAs ("●" *proP* P1, "▲" *proP* P2, "■" *rpoS*). Tryptophan was excited at 295 nm and the fluorescence was monitored at 355 nm. The y-axis is provided in terms of normalized fluorescence (FL~F~/FL~I~), determined by dividing the fluorescence at each mRNA concentration (FL~F~) by the fluorescence for 20nM protein only (FL~I~). DNA yielded no measurable fluorescence shift and is included as a negative control ("□" DNA) (B) Summary of binding affinities of ProQ for *in* *vitro* transcribed mRNAs.](pone.0079656.g004){#pone-0079656-g004}

Ribosome association of ProQ is not dependent on proP or proU {#s3.5}
-------------------------------------------------------------

We have shown that ProQ is found on translating ribosomes and this association appears to be mediated through mRNA. Because the only well characterized phenotype for a *proQ* mutant is a decrease in proline uptake, we posit that ProQ is involved in the translation of a subset of mRNAs in the cell, including one or more of the proline transporter mRNAs. We therefore asked whether the ribosome association of ProQ was dependent on these mRNA transcripts. We first examined the localization of ProQ in a Δ*proP* mutant, as *proP* mRNA is the predicted target of ProQ. We found, however, that the ribosome association of ProQ was similar in a Δ*proP* strain to that seen in the wild type strain ([Figures 1](#pone-0079656-g001){ref-type="fig"} and [5](#pone-0079656-g005){ref-type="fig"}). A genetic interaction has been reported between *proQ* and the *proW* and *proX* loci within the *proU* operon \[[@B36]\] and therefore, these genes may be regulated by ProQ. For this reason, we examined ProQ localization in strain backgrounds deleted for each member of the *proU* operon, as well as a deletion of the entire *proU* operon (*proVWX*), and deletion of both *proVWX* and *proP* together. In all backgrounds tested, ProQ is repeatedly found associated with 70S particles and polysomes ([Figure 5](#pone-0079656-g005){ref-type="fig"}). Thus, ProQ ribosome association is not absolutely dependent on any of these genes, and the ribosome association of ProQ may be due to one or more additional cellular mRNAs.

![Ribosome association of ProQ in various strain backgrounds.\
Cell lysates from various mutant backgrounds, as indicated, were separated by sucrose density ultracentrifugation and the localization of the ribosomal species (30S, 50S, 70s, polysomes) indicated. The localization of ProQ in the TCA-precipitated fractions is shown by immunoblot. Whole cell extracts from wild type, Δ*proQ* (JM6733), and the soluble lysate (Load) are included as indicated.](pone.0079656.g005){#pone-0079656-g005}

ProQ is necessary for biofilm formation, independent of ProP {#s3.6}
------------------------------------------------------------

Having shown that ProQ localization to the ribosome is independent of all known potential interactions involved in proline transport, we sought to expand the ProQ target list by looking for new Δ*proQ* phenotypes. A high throughput study implicated ProQ in biofilm formation; though, it only reported it as a hit and did not verify the result through plasmid-based complementation \[[@B28]\]. Under the conditions tested, a *proQ* mutant strain was found to be about 50% deficient in biofilm formation compared to wild type cells ([Figure 6](#pone-0079656-g006){ref-type="fig"}). This phenotype was complemented by transforming Δ*proQ* cells with a low-copy plasmid containing the *proQ* gene, plus 500 bp of sequence upstream of the translation start site. To test if this phenotype was independent of the role of ProQ in ProP regulation, we examined biofilm formation in a *proP* mutant strain. This strain was able to form biofilms as well as wild type. As a result, we conclude that the decrease in biofilm formation is unique to a *proQ* mutant and is independent of the ProQ-ProP interaction, though the reason for this deficiency remains unclear.

![Biofilm formation defect in a Δ*proQ* strain.\
Wild type (BW25113), Δ*proQ* (JM6733), and Δ*proP* (JM6753) strains were examined for formation of biofilms after 6 days. Strains were transformed with either empty vector (pMR20; shaded) or vector containing the *proQ* open reading frame, plus 500 bp of genomic sequence upstream of the translation start site (pMR20-ProQ; unshaded). Error bars represent 95% confidence intervals. A statistical difference is indicated (\*) between wild type and Δ*proQ* (JM6733) with a p-value \< 0.001.](pone.0079656.g006){#pone-0079656-g006}

Discussion {#s4}
==========

It has been proposed that ProQ is a translational regulator of *proP* mRNA \[[@B15]\]. This hypothesis has evolved and emerged out of a sort of "process of elimination", whereby it has been shown that i) *proP* transcript levels are unchanged in a *proQ* mutant \[[@B11]\] ii) no physical interaction can be detected between ProQ and ProP \[[@B36]\], and recently iii) ProP expression levels are affected by deletion of *proQ* \[[@B15]\]. In this study, we present the first *direct* evidence of a ProQ-translation link by demonstrating the association of ProQ with 70S particles, translating ribosomes, and 30S particles ([Figure 1](#pone-0079656-g001){ref-type="fig"}), but we have not detected a specific interaction between ProQ and *proP* mRNA at the ribosome. Some proteins that associate with the ribosome are involved in ribosome maturation and assembly \[[@B22],[@B37]\]. Deletion of these factors can result in defects in polysome profiles and decreased growth rates \[for reviews see [@B38]\]. These phenotypes are not observed in a *proQ* mutant (data not shown), and because of the relative dearth of phenotypes associated with a *proQ* deletion, it is unlikely that ProQ is an assembly factor. Thus far, ProQ has only been implicated in proline uptake \[[@B11]\] and stimulation of biofilm formation \[\[[@B28]\] and this study\]. For these reasons, we propose that ProQ has a very narrowly defined role in the translation of only a subset of mRNAs. This hypothesis is bolstered by the fact that the N-terminus of ProQ has been modeled on FinO, a highly specified translational regulator, which acts to specifically represses the translation of *traJ* mRNA by facilitating the interaction between *traJ* and the anti-sense RNA *finP* \[[@B39],[@B40]\]. As for the identities of the specific mRNA targets of ProQ, *proP* remains a favored target, but it is unknown if this effect is direct or indirect. Additionally, one or more additional targets are predicted to exist, based on the ProP-independent biofilm defect in a *proQ* mutant.

It had previously been shown that ProQ could bind to a model RNA, and that ProQ exhibits RNA chaperone-like activity \[[@B15]\]. Here we sought to explore the interaction between ProQ and RNA in three distinct ways. First, we examined the consequences of nuclease treatment on the association of ProQ with the ribosome ([Figure 3A](#pone-0079656-g003){ref-type="fig"}). Limited treatment of lysates with MNase caused a decrease in the number of polysomes observed after centrifugation. Specifically, the number of 3-mers and higher molecular weight species were significantly decreased. The loss of 3-mers is consistent with the increase in the number of 70S ribosomes observed. Though 3-mers were almost completely missing, a significant amount of ribosomes were still found to exist as 2-mers. MNase treatment had a large effect on the localization of ProQ, however, causing it to almost completely delocalize from 2-mers and 70S ribosomes. To further explore the requirement of mRNA for ProQ-ribosome association, we examined the ability of ProQ to bind to mRNA-free ribosomes *in vitro*. Not surprisingly, ProQ did not robustly associate with these ribosomes, and instead, seemed to prefer to bind to mRNA when present in the reactions ([Figure 3B](#pone-0079656-g003){ref-type="fig"}). For these reasons, we conclude that the mRNA being translated is very important for the comigration of ProQ with 70S and polysome species. Next, we used a quantitative *in vitro* binding assay to determine the affinity of ProQ for its predicted mRNA target, *proP* ([Figure 5](#pone-0079656-g005){ref-type="fig"}). The hypothesis that ProQ enhances *proP* translation, to the exclusion of other mRNAs, leads to the prediction that ProQ should selectively recognize *proP*. Under the conditions tested, ProQ binds tightly to *proP* mRNAs, but this binding is not selective, as ProQ binds with similar affinity to *rpoS* mRNA ([Figure 4](#pone-0079656-g004){ref-type="fig"}). Though we cannot rule out the possibility that *rpoS* is also a target of ProQ regulation, we believe this is unlikely since RpoS is a known regulator of *proP* transcription \[[@B6],[@B7]\], *proP* transcript levels are unchanged in a ProQ mutant \[[@B11]\], and a *proQ* deletion strain does not have the same lack of thermotolerance seen in an *rpoS* deletion strain \[[@B15]\]. If *proP* is a direct target of ProQ, some other unknown factor must confer specificity *in vivo*.

Little is known about ProQ, mechanistically. Previous studies have shown that exogenous expression of the N-terminal, FinO-like domain (residues 1-130) can partially complement the proline uptake deficiency of a *proQ* chromosomal deletion, and the N-terminus (1-130) is necessary and sufficient for binding to RNA \[[@B13],[@B15]\]. Our study of the domains of ProQ involved in ribosome association is not entirely consistent with these previous results. For example, even though the first 130 residues could bind to a model RNA, we do not observe ribosome association of a similar construct to any appreciable degree ([Figure 2B](#pone-0079656-g002){ref-type="fig"}). In this study, we expand the linker by seven residues to include amino acids 124-180, thus shortening the N-terminal domain from 1-130 to 1-123 ([Figure 2A](#pone-0079656-g002){ref-type="fig"}). This difference could account for the lack of ribosome association if residues 124-130 are necessary for RNA binding. Another inconsistency is observed with the C-terminus. In this study we find that a construct lacking residues 181-232 is associated with the ribosome in a manner comparable to plasmid-expressed wild type ProQ ([Figure 2B](#pone-0079656-g002){ref-type="fig"}). However, in previous studies, this construct did not suppress the proline uptake deficiency as well as a construct containing the C-terminal domain \[[@B13]\]. It must be noted that our present study sought only to identify the domains of ProQ which are important for ribosome association, independent of *proQ-proP* genetic interactions. Based on our results, we conclude that only the C-terminus is dispensable for ribosome association. Though we would predict that ribosome association is necessary for suppression of the proline uptake phenotype, we do not observe a direct dependence. This further complicates the mechanism by which ProQ enhances proline uptake.

A deeper exploration of the mechanism of ProQ action will be predicated on the discovery of *direct* mRNA targets. To date, finding these targets has been challenging. To begin the process, here we verified that ProQ is involved in promoting biofilm formation \[[@B28]\]. More importantly, we show that this phenotype is independent of ProP, yielding the first ProP-independent ProQ phenotype ([Figure 6](#pone-0079656-g006){ref-type="fig"}). Further independence of ProQ from ProP is demonstrated by the fact that ProQ is still associated with ribosomes in the absence of *proP* and *proU* mRNAs ([Figure 5](#pone-0079656-g005){ref-type="fig"}).

Though further studies are needed to definitively determine the function of the ribosomal association of ProQ, it is not unreasonable to propose a role for ProQ in translation initiation. Under non-dissociating conditions, we observe the highest concentration of ProQ in fractions corresponding to 70S and polysome species, but there is a modest, yet consistent, increase in signal under the peak corresponding to 30S particles, the first particle to bind during initiation ([Figure 1A](#pone-0079656-g001){ref-type="fig"}). This 30S localization is confirmed under dissociating conditions ([Figure 1B](#pone-0079656-g001){ref-type="fig"}). We present data showing that ProQ can bind tightly to mRNA *in vitro* ([Figure 4](#pone-0079656-g004){ref-type="fig"}), and mRNA integrity is necessary for robust ribosome association ([Figure 3](#pone-0079656-g003){ref-type="fig"}). Thus, ProQ is ideally positioned to function in translation initiation of its mRNA targets, perhaps by facilitating the interaction between 30S particles and these as-yet unidentified mRNAs.
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